TrialNature medicine2026

Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial.

Carlos Collet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.